Pediatric tinea capitis: Recognition and management

American Journal of Clinical Dermatology

Volumn 6, Issue 4, 2005, Pages 203-213

  Möhrenschlager, Matthias ^a   Seidl, Hans Peter ^a   Ring, Johannes ^a   Abeck, Dietrich ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; POVIDONE IODINE; SELENIUM SULFIDE; SHAMPOO; TERBINAFINE; THALLIUM;

ALOPECIA AREATA; ARTICLE; ATOPIC DERMATITIS; CHILDHOOD DISEASE; DERMATOMYCOSIS; DISEASE EXACERBATION; DOSE RESPONSE; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG DOSAGE FORM; DRUG DOSE REGIMEN; EPIDERMOLYSIS; FOLLICULITIS; FUNGAL VIRULENCE; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS TRANSMISSION; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HEADACHE; HEPATITIS; HUMAN; INFECTION RATE; LIVER TOXICITY; MICROSCOPY; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; PSORIASIS; RASH; SCAR FORMATION; SEBORRHEIC DERMATITIS; SIDE EFFECT; SKIN BIOPSY; STEVENS JOHNSON SYNDROME; TINEA CAPITIS; TOPICAL TREATMENT; TRICHOPHYTON TONSURANS; ULTRAVIOLET RADIATION;

ANTIFUNGAL AGENTS; CHILD; DIAGNOSIS, DIFFERENTIAL; HUMANS; TINEA CAPITIS;

EID: 23844513724     PISSN: 11750561     EISSN: 11750561     Source Type: Journal    
DOI: 10.2165/00128071-200506040-00001     Document Type: Article

References (68)

1. Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. Br J Dermatol 2000; 143: 53-8
2. Creach P, Auffret N, Buot G, et al. Microsporum canis tinea ciliaris and blepharitis. Ann Dermatol Venereol 1995; 122: 773-4
3. Khüffner J. Die acht Bücher des hochberühmten Aurelii Cornelii Celssi von beyderley Medicine. Meyntz: J. Schoeffer, 1531
4. Sabouraud RJA. Maladies du cuir chevelu. II. Les maladies desquamative: pityriasis, et al. opécies pelliculaires. Paris: Masson, 1904
5. Elewski BE. Tinea capitis: a current perspective. J Am Acad Dermatol 2000; 42: 1-20
6. Remak R. De morbo scrofulo. Berlin: Xaverus Hube, 1837
7. Schoenlein JL. Zur Pathogenese der Impetigines. Arch Anat Physiol Wiss Med 1839, 82
8. Aly R. Ecology, epidemiology and diagnosis of tinea capitis. Pediatr Infect Dis J 1999; 18: 180-5
9. Chmel L. Zoophilic dermatophytes and infection in man. In: Preusser HJ, editor. Medical Mycology. Stuttgart: Fischer, 1980: 61-6
10. Hurwitz S. Clinical Pediatric Dermatology. 2nd ed. Philadelphia (PA): WB Saunders, 1993
11. Chang S-E, Kang S-K, Choi J-H, et al. Tinea capitis due to Trichophyton rubrum in a neonate. Pediatr Dermatol 2002; 19: 356-8
12. Möhrenschlager M, Seidl HP, Holtmann C, et al. Tinea capitis et corporis due to Microsporum canis in an immunocompromised female adult patient. Mycoses 2003; 46 Suppl. 1: 19-22
13. Silverberg NB, Weinberg JM, DeLeo VA. Tinea capitis: focus on African American woman. J Am Acad Dermatol 2002; 46: S120-4
14. Fuller LC, Child FC, Higgins EM. Tinea capitis in southeast London: an outbreak of Trichophyton tonsurans infection [letter]. Br J Dermatol 1997; 136 (1): 139
15. Hay RJ, Clayton YM, de Silva N, et al. Tinea capitis in south east London: a new pattern of infection with public health implications. Br J Dermatol 1996; 135 (6): 955-8
16. Williams JV, Honig PJ, McGinley KJ, et al. Semiquantitative study of tinea capitis and asymptomatic carrier state in inner-city school children. Pediatrics 1995; 96: 265-7
17. Möhrenschlager M, Seidl HP, Ginter-Hanselmayer G, et al. Tinea capitis of childhood: incidence and pathogenetic role of Trichophyton tonsurans in Central Europe. J Am Acad Dermatol 2001; 45 (2): 320-1
18. Korstanje MJ, Staats CCG. Tinea capitis in northwestern Europe 1963-1993: etiologic agents and their changing prevalence. Int J Dermatol 1994; 33: 548-9
19. Lunder M, Lunder M. Is Microsporum canis infection about to become a serious dermatological problem? Dermatology 1992; 184: 87-9
20. Tietz HJ, Ulbricht HM, Sterry W. Tinea capitis in Deutschland: Ergebnisse einer epidemiologischen Analyse. Z Hautkr 1999; 74: 683-8
21. Möhrenschlager M, Veltmann V, Seidl HP, et al. Frequency and distribution of dermatophytic infections of childhood. 1991-2000 data from the Department of Dermatology and Allergy Biederstein, Technical University of Munich. JEADV 2001; 15 Suppl. 2: 219
22. Marples MJ. The ecology of Microsporum canis Bodin in New Zealand. J Hygiene 1956; 54: 378-87
23. Elewski BE, Hay RJ. International summit on cutaneous antifungal therapy, focus on tinea capitis, Boston (MA), Nov 11-13, 1994. Pediatr Dermatol 1996; 13 (1): 69-77
24. Lee JY, Hsu ML. Pathogenesis of hair infection and black dots in tinea capitis caused by Trichophyton violaceum: a histopathological study. J Cutan Pathol 1992; 19: 54-8
25. Möhrenschlager M, Bruckbauer H, Seidl HP, et al. Prevalence of tinea capitis and asymptomatic carriers in preschool children from Augsburg, Germany in 1996: results from the multicentric international study for risk-assessment of indoor and outdoor air pollution on allergy- and eczema morbidity (MIRIAM) [abstract]. Pediatr Dermatol 2004; 21: 380
26. Cuétara MS, del Palacio M, Noriega AR, et al. Prevalence of undetected tinea capitis in a prospective school survey in Madrid: emergence of new causative fungi. Br J Dermatol 1998; 138: 658-60
27. Sharma V, Hall JC, Knapp JF, et al. Scalp colonization by Trichophyton tonsurans in a urban pediatric clinic. Arch Dermatol 1988; 124: 1511-3
28. Hay RJ, Robles W, Midgley D, et al. Tinea capitis in Europe: new perspectives on an old problem. J Eur Acad Dermatol 2001; 15: 229-33
29. Leeming JG, Elliott TSJ. The emergence of Trichophyton tonsurans tinea capitis in Birmingham, UK. Br J Dermatol 1995; 133: 929-31
30. Buckley DM, Moss C, Austin G, et al. Trichophyton tonsurans infection in Birmingham [abstract]. Br J Dermatol 1996; 135 Suppl. 47: 21
31. Fuller LC, Child FJ, Midgley G, et al. Diagnosis and management of scalp ringworm. BMJ 2003; 326: 539-41
32. McGinnis MR, Tilton RC. Dermatophytes. In: Howard BJ, editor. Clinical and pathogenic microbiology. 2nd ed. St Louis (MO): Mosby-Year Book, 1993: 587-95
33. Gupta AK, Hofstader SL, Adam P, et al. Tinea capitis: an overview on management. Pediatr Dermatol 1999; 16: 171-89
34. Bode U, Dorn M, Ring J. Kerion Celsi. Fortschr Med 1980; 98: 1348-50
35. Hebert AA. Tinea capitis: current concepts. Arch Dermatol 1988; 124: 1554-7
36. Sharma V, Silverberg NB, Howard R, et al. Do hair care practices affect the acquisition of tinea capitis? Arch Pediatr Adolesc Med 2001; 155: 818-21
37. Babel DE, Baughman SA. Evaluation of the adult carrier state in juvenile tinea capitis. J Am Acad Dermatol 1989; 21: 1209-12
38. Honig PJ, Caputo GL, Leyden JJ, et al. Microbiology of kerion. J Pediatr 1993; 123: 422-4
39. Abeck D. Tinea capitis. In: Abeck D, Burgdorf W, Cremer H, editors. Common skin diseases in children. Darmstadt: Steinkopff, 2003: 115-9
40. Möhrenschlager M, Abeck D. Dermatologische Mykologie. In: Köhn FM, Ring J, editors. Fallstricke und Fehlerquellen in der Dermatologie. Wien: Springer, 2003: 122-31
41. Taplin D, Zaias N, Rebell G, et al. Isolation and recognition of dermatophytes on a new medium (DTM). Arch Dermatol 1969; 99: 203-9
42. Silverman RA, Elewski BE. Cutaneous fungal infections. 2nd ed. Malden (MA): Blackwell Science, 1998: 261-85
43. De Hoog GS, Guarro J, Gené J, et al. Atlas of clinical fungi. 2nd ed. Utrecht: Centraalbureau voor Schimmelcultures/Reus: Universitat Rovira i Virgili, 2000
44. Kefalidou S, Odia S, Gruseck E, et al. Wood's light in Microsporum canis positive patients. Mycoses 1997; 40: 461-3
45. Elewski BE. Cutaneous mycoses in children. Br J Dermatol 1996; 134 Suppl. 46: 7-11
46. Dostrovsky A. Campaign against contagious diseases in Palestine. Hahinuch 1925; 2: 96-103
47. Gupta AK, Sauder DN, Shear NH. Antifungal agents: an overview. J Am Acad Dermatol 1994; 30: 677-98
48. Möhrenschlager M, Korting HC, Seidl HP, et al. Tinea capitis. Hautarzt 2002; 53: 788-94
49. Sheretz E. Are laboratory studies necessary for griseofulvin therapy? [letter]. J Am Acad Dermatol 1990; 22: 1103
50. Abeck D, Möhrenschlager M. Tinea capitis: ein ungelöstes Problem. In: Plewig G, Prinz J, editors. Fortschritte der praktischen Dermatologie und Venerologie 2002. Berlin: Springer, 2003: 463-6
51. Möhrenschlager M, Schnopp C, Fesq H, et al. Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole. Br J Dermatol 2000; 143: 1011-5
52. Solomon BA, Collins R, Sherma R, et al. Fluconazole in the treatment of tinea capitis in children. J Am Acad Dermatol 1997; 37 (2 Pt 1): 274-5
53. Haria M, Bryson HM, Goa KL. Itraconazole. Drugs 1996; 51: 585-620
54. Blumer JL. Pharmacologic basis for the treatment of tinea capitis. Pediatr Infect Dis J 1999; 18: 191-9
55. Dastghaib L, Azizzadeh M, Jafari P. Therapeutic options for the treatment of tinea capitis: griseofulvin versus fluconazole. J Derm Treat 2005; 16: 43-6
56. Koumantaki E, Kakourou T, Rallis E, et al. Doubled dose of oral terbinafine is required for Microsporum canis tinea capitis. Pediatr Dermatol 2001; 18: 339-42
57. Conjeevaram G, Vonghtavaravat V, Sumner R, et al. Terbinafine-induced hepatitis and pancytopenia. Dig Dis Sci 2001; 46: 1714-6
58. Friedlander SF. Terbinafine dose and complete cure rate in tinea capitis [abstract]. JEADV 2002; 16 Suppl. 1: 242
59. Committee on Infectious Diseases. Tinea capitis. In: Peter G, editor. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Chicago (IL): American Academy of Pediatrics, 1997: 523-5
60. Hussain I, Muzzaffar F, Rashid T, et al. A randomized comparative trial of treatment of kerion Celsi with griseofulvin plus oral prednisolone vs griseofulvin alone. Med Mycol 1999; 37: 97-9
61. Honig PJ, Caputo GL, Leyden JJ, et al. Treatment of kerions. Pediatr Dermatol 1994; 11: 69-71
62. Keipert JA. Beneficial effect of corticosteroid therapy in Microsporum canis kerion. Aust J Dermatol 1984; 25: 127-30
63. Allen HB, Honig PJ, Leyden JJ, et al. Selenium sulphide: adjunctive therapy for tinea capitis. Pediatrics 1982; 69: 81-3
64. Neil G, Hanslo D. Control of the carrier state of scalp dermatophytes. Pediatr Inf Dis J 1990; 9: 57-8
65. Midgley G, Clayton YM. Distribution of dermatophytes and candida spores in the environment. Br J Dermatol 1972; 86: 69-77
66. Mancianti F, Pedonese F, Zullino C. Efficacy of oral administration of itraconazole to cats with dermatophytosis caused by Microsporum canis. J Am Vet Med Assoc 1998; 213: 993-5
67. Fenner A. Dermatophyten-Impfstoffe in der Veterinärmedizin [abstract]. Mycoses 2002; 45: 222
68. McKenzie DWR. Hairbrush diagnosis in detection and eradication of non-fluorescent scalp ringworm. BMJ 1963; 10: 363-5